Market Place
Sourcing Support
Karyopharm reports interim data from eltanexor Phase I/II study
04 May 2023 //
CLINICAL TRIALS ARENA
Karyopharm Announces Presentation Data from pH 2 Study of Single-Agent Eltanexor
03 May 2023 //
BUSINESSWIRE
Karyopharm Receives ODD from FDA for Eltanexor in Myelodysplastic Syndromes
24 Jan 2022 //
PRNEWSWIRE
Karyopharm Announces Dosing of First Patient in a Phase 2 Stud
21 Oct 2021 //
PRESS RELEASE
Karyopharm Therapeutics Announces Updated Data of Eltanexor
09 Jun 2021 //
PRNEWSWIRE
Approval of Ph I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation
25 Nov 2020 //
PRNEWSWIRE
Karyopharm & Antengene Sign Exclusive License Agreement Selinexor & KPT-9274
24 May 2018 //
NASADQ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.